tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Lifeist Wellness Aims for Canadian CELLF 2.0 Approval

Lifeist Wellness Aims for Canadian CELLF 2.0 Approval

Lifeist Wellness (TSE:LFST) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Lifeist Wellness Inc.’s subsidiary Mikra is seeking Canadian approval for CELLF 2.0, a cellular health product designed to enhance energy, focus, and longevity. The successful application for a Natural Product Number would enable Canadian marketing and distribution, capitalizing on positive clinical trials highlighting CELLF 2.0’s cognitive and anti-aging benefits. Lifeist aims to expand its natural, scientifically-backed wellness products to a broader market in 2024.

For further insights into TSE:LFST stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1